The proposed bill, if enacted, would amend current statutes regarding the dispensing of prescription opioid containers. Specifically, it would eliminate the requirement that the container of a schedule II controlled substance that is an opioid, directly dispensed by a pharmacist and not for immediate use, have a red cap. Instead, the new law would require that such containers have a warning label prescribed by the board about potential addiction. This change aims to simplify the labeling requirements for opioid prescriptions while maintaining a focus on informing patients about the risks associated with these medications. Additionally, the bill would make several technical adjustments to existing language. For instance, it would modify the definition of "readily retrievable" prescriptions and update the requirements for electronic prescription orders. The bill would also remove the provision allowing the board to waive the red cap requirement if it is not feasible due to specific dosage forms or packaging types. Overall, these updates are intended to streamline the regulatory framework surrounding opioid prescriptions while ensuring that essential safety information remains accessible to patients.

Statutes affected:
Introduced Version: 36-2525
House Engrossed Version: 36-2525
Chaptered Version: 36-2525